The answer from your Doctor may be 50/50 with a leaning towards Pegasys, I honestly think they are just better at marketing than Peg-intron. This study and a few others suggests that at least for genotype 1 Peg-intron is “better”.
Overall, genotype 1 patients treated with Peg-Intron were more likely to achieve sustained virological response 24 […]

To cut a very long story short they are looking at making treatment part of the guidelines for everybody who has Hepatitis C, not just those with moderate or severe liver damage. I’m not convinced that is a good idea myself but some may consider it good news. On the bad news side nothing, zilch, […]

Leeds ninth stop on FaCe It tour
The FaCe It photography exhibition will be unveiled in Leeds’s Central Square on Friday 10th February 2006.
Local resident Harvey Huckerby, whose picture is included in the display, will launch the exhibition to media at 10am on the 10th.
For further information on the event, which will last for two days, […]

Another one hits the “track”.
Schering-Plough Reports FDA Grants Fast Track Designation to Oral HCV Protease Inhibitor SCH 503034
Schering-Plough today reported that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its investigational oral hepatitis C protease inhibitor (SCH 503034), currently in Phase II clinical development for the treatment of chronic hepatitis […]

NM283 is another drug in trials that is showing some positive results with the hard to treat genotype 1 Hepatitis C. You know the drill, years away if ever but still worth keeping an eye on.
Idenix Pharmaceuticals announced 4-week data today from an ongoing phase IIb clinical trial demonstrating that treatment with valopicitabine NM […]

The Vertex VX-950 does look impressive even at this early stage of clinical trials. I wouldn’t hold your breath but it looks worthy of keeping an eye on.
Data announced today by Vertex show that VX-950, an investigational hepatitis C virus (HCV) protease inhibitor, dosed in combination with pegylated interferon alfa-2a , achieved a […]

As with all things new and medical don’t hold your breath for real world results but its encouraging that people are looking for solutions.

A Japanese research team says it has found a method that prevents the hepatitis-C virus from multiplying.
The method deals with cells infected with the virus, not the virus itself, meaning drugs could […]

Talking of treatment, European approvals just announced are going to have a small impact on treatment in some cases. If you have genotype 1, a low viral load, and are starting treatment with PegIntron (not Pegasys, at least at present,) then you need to be aware of the changes. Those that achieve ‘undetectable’ status at […]